Literature DB >> 11665961

The utility of immunologic laboratory tests in patients with rheumatic diseases.

A Kavanaugh.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11665961     DOI： 10.1002/1529-0131(200110)44:10<2221::aid-art383>3.0.co;2-t

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

1.  Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

Authors:  Loes van den Berg; Hans Nossent; Ole Rekvig
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

2.  A proposed model for effective collaboration between rheumatologists and clinical pathologists for the diagnosis of autoimmune rheumatic diseases.

Authors:  Nicola Bizzaro; Gabriella Morozzi
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

3.  Clinical evaluation of cobas core anti-dsDNA EIA quant.

Authors:  Concepción González; Paloma Guevara; Belén García-Berrocal; José Alejandro Navajo; José Manuel González-Buitrago
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

4.  Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.

Authors:  Jason W Bauer; Michelle Petri; Franak M Batliwalla; Thearith Koeuth; Joseph Wilson; Catherine Slattery; Angela Panoskaltsis-Mortari; Peter K Gregersen; Timothy W Behrens; Emily C Baechler
Journal:  Arthritis Rheum       Date:  2009-10

Review 5.  Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases: It is all about the patient!

Authors:  Allan S Wiik; Nicola Bizzaro
Journal:  Auto Immun Highlights       Date:  2012-04-11

Review 6.  The use and abuse of commercial kits used to detect autoantibodies.

Authors:  Marvin J Fritzler; Allan Wiik; Mark L Fritzler; Susan G Barr
Journal:  Arthritis Res Ther       Date:  2003-06-09       Impact factor: 5.156

Review 7.  Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?

Authors:  Hans C Nossent; Ole Petter Rekvig
Journal:  Arthritis Res Ther       Date:  2005-02-10       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.